Search Results

BIOCORP announced that they have received 510 clearance from the U.S. Food & Drug Administration to market Mallya, its smart medical device that connects insulin pens.

BIOCORP announces the signature of a partnership agreement with Novo Nordisk for the commercialization of Mallya, initially in Japan.

BIOCORP and Merck KGaA, Darmstadt, Germany, will collaborate on the development and global distribution of a specific version of Mallya for drug delivery devices BIOCORP and Merck KGaA, Darmstadt, Germany, are extending their collaboration after an already ongoing program BIOCORP will receive payments for the development and additional revenues from sales after launch following the completion of certain milestones.

BD, a leading global medical technology company, and Biocorp, a medical device and delivery systems manufacturer based in France, announced that they have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics.

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, and SANOFI announced the completion of the development of SoloSmart® , on the opening of the EASD annual meeting in Stockholm, Sweden.

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, announces the signature of a new agreement with H&T Presspart, whereby H&T Presspart is licenced to sell and promote BIOCORP’s InspairTM smart add-on device for metered-dose inhalers.

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, and Merck, a leading science and technology company, announce an agreement for the development and supply of a specific version of Mallya device to monitor treatment adherence in the field of HGH.

BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, announces an agreement with Novo Nordisk, a world leader in diabetes care, for the development and distribution of a Mallya smart add-on device for the Novo Nordisk FlexTouch pen used by people with diabetes.

BIOCORP, a French company specialized in the design, development and manufacturing of innovative medical devices, announces the signature of new partnerships with Health2Sync and SocialDiabetes, companies headquartered in Taiwan and Spain, respectively.

BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and connected solutions in the health sector and Diabeloop, a young company, pioneer in therapeutic artificial intelligence with personalized and automated solutions for the management of diabetes treatment, announce today a cooperation agreement.